Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjusted Steroid Therapy in Children With Idiopathic Nephrotic Syndrome
NCT02649413Phase 4Unknown
- Sponsor
- Rabin Medical Center
- Start
- Mar 2016
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in Idiopathic nephrotic syndrome (INS), minimal change disease (MCD), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
prednisone
03
Conditions
Idiopathic nephrotic syndrome (INS)minimal change disease (MCD)
Beyond the preview
Go deeper on NCT02649413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02649413.